health standard journal
  • Just In
  • Editorial
  • Paper/Article
  • Milestone
  • Discovery
  • HSJ tv
No Result
View All Result
No Result
View All Result
Home Just In

Russian’s Sputnik V free for citizens, cheaper than other COVID-19 vaccines

Sputnik V vaccine is 95 percent effective according to second interim analysis of clinical trial data, developers say.

Health standard journal by Health standard journal
November 24, 2020
in Discovery
0
Russian’s Sputnik V free for citizens, cheaper than other COVID-19 vaccines
16
SHARES
157
VIEWS
Share on FacebookShare on TwitterShare on LinkedInShare on Whatsapp

The Russian drug, Sputnik V is said to cost less than $20 on international markets but will be free of charge for Russian citizens in a bid to produce more than a billion doses at home and abroad next year.

The announcement, which was made on the official Sputnik V Twitter account on Tuesday, is coming after RDIF and the Gamaleya National Center said new clinical trial data based on 39 confirmed cases and 18,794 patients who got both shots had shown that Sputnik V was 91.4 percent effective on day 28 and more than 95 percent effective on day 42.

Some volunteers had short-term minor adverse effects such as pain at the injection site and flu-like symptoms including fever, weakness, fatigue, and headaches, it said.

RDIF has said as of November 11, no serious side effects had been reported during the Sputnik V phase three trial.

RelatedPosts

Pfizer, BioNTech seek emergency use of COVID-19 vaccine in US

Pfizer, BioNTech seek emergency use of COVID-19 vaccine in US

November 20, 2020
Oxford COVID-19 vaccine to help older people build immunity against virus

Oxford COVID-19 vaccine to help older people build immunity against virus

November 20, 2020

Scientists Unravel the Mystery of Anesthesia

November 4, 2020

Kirill Dmitriev, head of Russia’s RDIF sovereign wealth fund, Sputnik V revealed that vaccine would be priced significantly lower than rivals with similar efficacy levels.

The Sputnik vaccine, named after the Soviet-era satellite will be administered in two shots and given to the Russian citizens free of charge. Mass vaccination in Russia, which has the world’s fifth-highest number of recorded COVID-19 cases, has yet to begin as so-called Phase III clinical trials continue.

British drugs group AstraZeneca and the University of Oxford, which has pledged it will not make a profit on the vaccine during the pandemic, has reached agreements with governments and international health organisations that put its cost at about $2.50 a dose. Pfizer’s vaccine costs about $20 a dose, while Moderna’s is $15-25, based on agreements the companies have struck to supply their vaccines to the US government.

 

Tags: COVID-19RussiaSputnik V
Advertisement Banner
Previous Post

Pfizer, BioNTech seek emergency use of COVID-19 vaccine in US

Next Post

THE RISE OF PROSTATE CANCER IN NIGERIA

Health standard journal

Health standard journal

Related Posts

Pfizer, BioNTech seek emergency use of COVID-19 vaccine in US
Just In

Pfizer, BioNTech seek emergency use of COVID-19 vaccine in US

November 20, 2020
Oxford COVID-19 vaccine to help older people build immunity against virus
Just In

Oxford COVID-19 vaccine to help older people build immunity against virus

November 20, 2020
A picture of someone in a surgical ward
Discovery

Scientists Unravel the Mystery of Anesthesia

November 4, 2020
New Study Links Poverty to Higher Death Rates from Heart Failure
Discovery

New Study Links Poverty to Higher Death Rates from Heart Failure

October 30, 2020
Scientists discover largest bacteria-eating virus which blurs line between living and nonliving
Discovery

Scientists discover largest bacteria-eating virus which blurs line between living and nonliving

June 23, 2020
Bacteria hiding in indoor dust could spread antibiotic resistance
Discovery

Bacteria hiding in indoor dust could spread antibiotic resistance

June 23, 2020
Load More
Next Post
THE RISE OF PROSTATE CANCER IN NIGERIA

THE RISE OF PROSTATE CANCER IN NIGERIA

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest Stories

COVID-19: NEC endorse May and Baker, FG’s local vaccine production  

COVID-19: NEC endorse May and Baker, FG’s local vaccine production  

January 22, 2021
Germany crosses 50,000 total COVID deaths

Germany crosses 50,000 total COVID deaths

January 22, 2021

January 22, 2021
COVID-19: Biden mandates mask wearing on federal property

Biden restores ties with WHO cut by Trump

January 21, 2021
COVID-19: Biden mandates mask wearing on federal property

COVID-19: Biden mandates mask wearing on federal property

January 21, 2021
Sickle Cell Foundation Nigeria to start bone marrow transplant in February

Sickle Cell Foundation Nigeria to start bone marrow transplant in February

January 20, 2021
health standard journal

Health Standard Journal

Health Standard Journal (HSJ) is a monthly medical publication from the stable of HSJ Media Ltd. It is Journal of Clinical Excellence which was borne out of a strong will to provide adequate and effective information to healthcare providers across various sub-specialties in the healthcare industry.

Categories

  • Discovery
  • Editorial
  • HSJ tv
  • Just In
  • Milestone
  • Paper/Article
  • stories
  • Uncategorized
How to Spot Difficult-to-Diagnose Skin Cancers

How to Spot Difficult-to-Diagnose Skin Cancers

by Health standard journal
10 months ago
0

Differentiating between benign skin lesions and melanoma to identify cancers with unusual presentation can be tricky, and it typically makes...

FEDERAL GOVERNMENT SHOULD GO BEYOND BANNING SNIPER

FEDERAL GOVERNMENT SHOULD GO BEYOND BANNING SNIPER

by Health standard journal
10 months ago
0

Sniper, which is technically described as a DDVP (2,2-Dichlorovinyl dimethyl phosphate compound), until recently; was a very effective insecticide. The...

Prev Next
  • Home
  • About Us
  • Contact
  • Advertise
  • Privacy Policy
  • Subscription

© 2020 Health Standard Journal - All rights reserved | Designed by 90th Projects.

No Result
View All Result
  • Just In
  • Editorial
  • Paper/Article
  • Milestone
  • Discovery
  • HSJ tv

© 2020 Health Standard Journal - All rights reserved | Designed by 90th Projects.